Agile Therapeutics
AGRX
$0.40
Share price
0.00%
Change (1 day)
-93.94%
Change (1 year)
Categories
Agile Therapeutics (AGRX) - P/B ratio
P/B ratio as of April 2024 : -0.2210
According to Agile Therapeutics
's latest financial reports the company has a price-to-book ratio of -0.2210.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Agile Therapeutics - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.3946 | -76.27% |
| 2022-12-31 | -1.66 | -110.99% |
| 2021-12-31 | 15.1 | 197.52% |
| 2020-12-31 | 5.09 | 33.34% |
| 2019-12-31 | 3.82 | 288.77% |
| 2018-12-31 | 0.9814 | -61.24% |
| 2017-12-31 | 2.53 | -34.68% |
| 2016-12-31 | 3.88 | -47.07% |
| 2015-12-31 | 7.32 | 130.44% |
| 2014-12-31 | 3.18 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | -2,417.15% | 🇺🇸 USA |
 Pfizer PFE | 1.61 | -828.69% | 🇺🇸 USA |
 Merck MRK | 8.83 | -4,095.85% | 🇺🇸 USA |
 TherapeuticsMD TXMD | 0.7688 | -447.90% | 🇺🇸 USA |